Sun Life Financial Inc.

Sun Life reported underlying net income of CAD 1.12 billion, up from CAD 1.02 billion a year ago, and underlying EPS of CAD 2.02, up 13% year over year. Underlying ROE was 19.1%; reported net income was CAD 1.01 billion versus CAD 716 million a year ago. The quarter benefited from strong contributions in Canada, Asia, and the U.S.; Sun Life Asset Management underlying net income was CAD 262 million, up 4% year over year, while Canada underlying net income was CAD 427 million, up 23%, U.S. underlying net income increased 15%, and Asia underlying net income increased 21%. Capital remained strong with a LICAT ratio of 145%, holding company cash of CAD 2.3 billion, book value per share of CAD 42.49, financial leverage of 23.8%, and total CSM of CAD 15.3 billion, up 12% year over year. Management did not provide formal next-quarter or full-year numerical guidance beyond reiterating medium-term targets: underlying EPS growth above 10%, underlying ROE approaching 20%, dividend ratio within 40%-50%, and asset-management operating margin expected to be over 30% over the coming years.

Kevin Strain said the quarter was proof that Sun Life is becoming a more diversified, global, growth-oriented company, with broad-based earnings growth across Canada, Asia, U.S. health/risk, and asset management. He emphasized strategic momentum in AI, digital tools, and the unified Sun Life Asset Management platform, along with growth in alternatives and India. His tone was upbeat but disciplined, repeatedly framing the business as well-positioned through strong capital, execution, and diversification.

Tim Deacon highlighted the hard numbers behind the quarter: underlying net income of CAD 1.12 billion, EPS of CAD 2.02, reported net income of CAD 1.01 billion, and capital metrics including a 145% LICAT ratio, CAD 42.49 book value per share, and 41% organic capital generation, above the 30%-40% guidance range. He explained the gap between underlying and reported earnings as mainly acquisition/integration costs in SLC, intangible amortization, and modestly unfavorable market impacts. He also noted strong capital raising of CAD 4.7 billion and deployment of CAD 6.2 billion in asset management, plus return of about half a billion dollars to shareholders through dividends and repurchase activity under the NCIB.

Analysts focused heavily on U.S. stop loss and dental, Asia’s Hong Kong/MCV exposure, Canada’s unusually strong insurance experience, and SLC’s path to higher earnings. Management said stop loss morbidity was impacted by expected seasonal IBNR reserve buildup, that margins remain in the mid-70s loss-ratio range, and that 1-1-26 pricing is still early but supported by emerging experience and analytics. On dental, management said Medicaid/government business will remain a headwind for this year, membership will likely stay lower, and the business is being reshaped toward a smaller, more profitable commercial mix over one to two years. For Asia and Hong Kong, management said MCV is about 30% of Hong Kong sales, the business remains diversified and competitive, and current margin levels are considered appropriate in the present environment.